| Authors: |
Piccart M; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be., Hortobagyi GN; Department of Breast Medical Oncology, Multidisciplinary Breast Cancer Research Program, University of Texas MD Anderson Cancer Center, Houston, USA., Campone M; Institut de Cancérologie de l'Ouest, René Gauducheau, Centre de Recherche en Cancérologie, Nantes Saint Herblain, France., Pritchard KI; Department of Medicine, Sunnybrook Odette Cancer Centre and the University of Toronto, Toronto, Canada., Lebrun F; Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Ito Y; Department of Breast Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo., Noguchi S; Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Perez A; Breast Cancer Centers, Memorial Cancer Institute, Hollywood., Rugo HS; Breast Oncology and Clinical Trials Education, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA., Deleu I; Oncologic Centre, AZ Nikolaas, Sint-Niklaas, Belgium., Burris HA 3rd; Sarah Cannon Research Institute, Nashville, USA., Provencher L; Centre des Maladies du Sein Deschênes-Fabia, CHU-Hôpital du Saint Sacrement, Québec, Canada., Neven P; Multidisciplinary Breast Centre and Department of Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium., Gnant M; Department of Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria., Shtivelband M; Ironwood Cancer & Research Centers, Chandler., Wu C; Novartis Pharmaceuticals Corporation, East Hanover., Fan J; Novartis Pharmaceuticals Corporation, East Hanover., Feng W; Novartis Pharmaceuticals Corporation, East Hanover., Taran T; Novartis Pharmaceuticals Corporation, East Hanover., Baselga J; Memorial Sloan-Kettering Cancer Center, New York, USA. |
